Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients
Pharmaceuticals · 21.10.2025 · 18 (10) · 1592
DOI: 10.3390/ph18101592 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 21.10.2025. Verfasst von Andreea Silvia Pirvu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, Romania.
Abstract (Originalsprache)
Cyclodextrins (CDs) have traditionally been recognized as excipients that enhance solubility and stability of drugs. However, growing evidence shows that CDs themselves can act as active therapeutic agents. Their unique supramolecular properties enable them to interact with biological membranes, mobilize cholesterol, and modulate immune responses. This review highlights four therapeutic areas where CDs demonstrate particular promise. First, in gene and mRNA therapy, cationic CD derivatives form nanoparticles that protect nucleic acids, promote endosomal escape, and achieve targeted delivery. Second, in neurodegenerative disorders such as Niemann–Pick type C and Alzheimer’s disease, hydroxypropyl-β-CD facilitates cholesterol clearance and reduces pathological lipid accumulation. Third, in detoxification, the γ-CD derivative sugammadex exemplifies a clinically approved agent that encapsulates neuromuscular blockers to reverse anesthesia. Finally, CDs have emerged as safe vaccine adjuvants, inducing robust systemic and mucosal immunity with reduced IgE responses compared to alum. Together, these examples illustrate a paradigm shift: CDs are not only versatile excipients but also active molecules with direct therapeutic effects. Future translation will require careful optimization of safety, scalability, and regulatory compliance, but CDs are poised to contribute meaningfully to next-generation medicines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Research Methodology Department, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Pediatric Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Anatomy, University of Medicine and Pharmacy, Discipline of Anatomy, 200349 Craiova, Romania.
Förderung
- University of Medicine and Pharmacy of Craiova, Romania
Zitieren
APA
Pirvu, A. S., Varut, R. M., Trasca, D. M., Stoica, G. A., Radivojevic, K., Carmen, S., Arsenie, C. C., & Popescu, C. (2025). Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients. Pharmaceuticals, 18(10), 1592. https://doi.org/10.3390/ph18101592
Vancouver
Pirvu AS, Varut RM, Trasca DM, Stoica GA, Radivojevic K, Carmen S, et al. Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients. Pharmaceuticals. 2025;18(10):1592. doi:10.3390/ph18101592
BibTeX
@article{Pirvu2025,
author = {Pirvu, Andreea Silvia and Varut, Renata-Maria and Trasca, Diana-Maria and Stoica, George Alin and Radivojevic, Kristina and Carmen, Sirbulet and Arsenie, Cristian Cosmin and Popescu, Cristina},
title = {Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {10},
pages = {1592},
doi = {10.3390/ph18101592}
}
EUVIMED